Cambrex Charles City, Inc., a subsidiary of Cambrex Corporation of East Rutherford, New Jersey, manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates for both the generic and branded human pharmaceutical markets. As a result of recent rapid growth, Cambrex has identified the need for a capital expansion to increase manufacturing capacity. The proposed facility will be built and outfitted with commercial scale cGMP (Current Good Manufacturing Practices) assets, 45,000 square feet of warehousing, QC labs, internal roads, and a second facility entrance. The board awarded Cambrex tax benefits through the HQJP to create 32 jobs at a qualifying wage of $14.93 per hour.
Cambrex Charles City is located in North Central Iowa on a 45-acre site in Charles City. The facility manufactures APIs, fine chemicals and pharmaceutical intermediates for a wide range of applications.
